Nav: Home

Extraordinary immune cells may hold the key to managing HIV

December 04, 2008

People who manage to control HIV on their own are providing scientists with valuable information about how the immune system eliminates virus-infected cells. A new study, published in the December 4th issue of Immunity, a Cell Press publication, identifies specific characteristics of the immune cells that successfully destroy HIV-infected cells and may drive strategies for developing the next generation of HIV vaccines and therapies.

Long-term nonprogressors (LTNPs) or elite controllers are rare individuals who are able to contain HIV for many years without any type of antiretroviral therapy. "Direct and indirect lines of evidence in humans and animal models suggest that virus-specific immune cells, called CD8+ T cells, mediate this control. However, the mechanisms by which this occurs remain unknown," says senior study author Dr. Mark Connors from the National Institute of Allergy and Infectious Disease in Bethesda, Maryland.

Using sophisticated new tools that can precisely measure the killing capacity of HIV-specific CD8+ T cells on a per-cell basis, Dr. Connors and colleagues compared how cells from LTNPs and progressors battle HIV by destroying infected cells. The CD8+ T cells of LTNPs efficiently eliminated infected cells by successfully loading granules with the proteins necessary for poking holes in the membranes of target cells and subsequently delivering a death-inducing molecule called granzyme B to cells infected with HIV.

In contrast, the CD8+ T cells of progressors lysed HIV-infected cells poorly. The researchers went on to show that CD8+ T cells of progressors were deficient in their ability to load lytic granules and deliver cytotoxic proteins to target cells. Elimination of infected cells readily distinguished LTNPs from progressors and was not restored in patients on antiretroviral therapy. However, the diminished abilities of the HIV-specific CD8+ T cells of progressors were reversible after treatment with phorbol ester and calcium ionophore, suggesting that these cells may retain the capacity to perform at the level seen in LTNPs.

Taken together, these findings demonstrate that LTNPs exhibit a superior ability to kill HIV-infected cells. "This capacity of CD8+ T cells is the function that is the best correlate of immunologic control we have observed thus far," says Dr. Stephen Migueles, the lead author of the study. He went on to say, "It will be very important for us to determine whether this is also predictive of immunologic control in vaccines. Clear correlates of immunologic control of HIV in chronic infection or vaccines have been sought for many years. If this function is also predictive of control in vaccines, this could be an extremely important milestone for HIV vaccine research."
-end-
The researchers include Stephen A. Migueles, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Christine M. Osborne, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD Cassandra Royce, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Alex A. Compton, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Rohan P. Joshi, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Kristin A. Weeks, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Julia E. Rood, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Amy M. Berkley, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Jonah B. Sacha, University of Wisconsin, Madison, WI; Nancy A. Cogliano-Shutta, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Margaret Lloyd, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Gregg Roby, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Richard Kwan, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Mary McLaughlin, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Sara Stallings, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Catherine Rehm, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Marie A. O'Shea, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; JoAnn Mican, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Beverly Z. Packard, OncoImmunin, Gaithersburg, MD; Akira Komoriya, OncoImmunin, Gaithersburg, MD; Sarah Palmer, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD; Ann P. Wiegand, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD; Frank Maldarelli, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD; John M. Coffin, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD; John W. Mellors, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, PA; Claire W. Hallahan, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Dean A. Follman, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Mark Connors, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Cell Press

Related Hiv Articles:

Defective HIV proviruses reduce effective immune system response, interfere with HIV cure
A new study finds defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV.
1 in 7 people living with HIV in the EU/EEA are not aware of their HIV status
Almost 30,000 newly diagnosed HIV infections were reported by the 31 European Union and European Economic Area (EU/EEA) countries in 2015, according to data published today by ECDC and the WHO Regional Office for Europe.
Smoking may shorten the lifespan of people living with HIV more than HIV itself
A new study led by researchers at Massachusetts General Hospital finds that cigarette smoking substantially reduces the lifespan of people living with HIV in the US, potentially even more than HIV itself.
For smokers with HIV, smoking may now be more harmful than HIV itself
HIV-positive individuals who smoke cigarettes may be more likely to die from smoking-related disease than the infection itself, according to a new study published in the Journal of Infectious Diseases.
Patients diagnosed late with HIV infection are more likely to transmit HIV to others
An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.
The Lancet HIV: New HIV infections stagnating at 2.5 million a year worldwide
A major new analysis from the Global Burden of Disease 2015 study, published today in The Lancet HIV journal, reveals that although deaths from HIV/AIDS have been steadily declining from a peak in 2005, 2.5 million people worldwide became newly infected with HIV in 2015, a number that hasn't changed substantially in the past 10 years.
NIH scientists discover that defective HIV DNA can encode HIV-related proteins
Investigators from the National Institutes of Health have discovered that cells from HIV-infected people whose virus is suppressed with treatment harbor defective HIV DNA that can nevertheless be transcribed into a template for producing HIV-related proteins.
Study examines risk of HIV transmission from condomless sex with virologically suppressed HIV infection
Among nearly 900 serodifferent (one partner is HIV-positive, one is HIV-negative) heterosexual and men who have sex with men couples in which the HIV-positive partner was using suppressive antiretroviral therapy and who reported condomless sex, during a median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission, according to a study appearing in the July 12 issue of JAMA, an HIV/AIDS theme issue.
HIV vaccine design should adapt as HIV virus mutates
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
Charlie Sheen's HIV disclosure may reinvigorate awareness, prevention of HIV
Actor Charlie Sheen's public disclosure in November 2015 that he has the human immunodeficiency virus (HIV) corresponded with the greatest number of HIV-related Google searches ever recorded in the United States, according to an article published online by JAMA Internal Medicine.

Related Hiv Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...